Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MITO

Stealth BioTherapeutics (MITO) Stock Price, News & Analysis

Stealth BioTherapeutics logo

About Stealth BioTherapeutics Stock (NASDAQ:MITO)

Advanced Chart

Key Stats

Today's Range
$0.32
$0.32
50-Day Range
$0.31
$0.32
52-Week Range
$0.16
$1.03
Volume
N/A
Average Volume
946,105 shs
Market Capitalization
$23.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MITO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stealth BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

MITO Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Headlines

MITO Stock Analysis - Frequently Asked Questions

Stealth BioTherapeutics Corp (NASDAQ:MITO) issued its earnings results on Thursday, August, 5th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01.

Stealth BioTherapeutics (MITO) raised $81 million in an initial public offering (IPO) on Friday, February 15th 2019. The company issued 6,200,000 shares at $12.00-$14.00 per share. Jefferies, Evercore ISI and BMO Capital Markets served as the underwriters for the IPO and Nomura was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stealth BioTherapeutics investors own include Tesla (TSLA), TherapeuticsMD (TXMD), NIO (NIO), Plug Power (PLUG), Allena Pharmaceuticals (ALNA), SCYNEXIS (SCYX) and Tonix Pharmaceuticals (TNXP).

Company Calendar

Last Earnings
8/05/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MITO
CIK
1696396
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$52.53 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-142.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.68
Quick Ratio
3.68

Sales & Book Value

Annual Sales
$21.09 million
Price / Sales
1.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.79) per share
Price / Book
-0.41

Miscellaneous

Outstanding Shares
73,552,000
Free Float
N/A
Market Cap
$23.54 million
Optionable
Not Optionable
Beta
1.46
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:MITO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners